Heart Transplantation clinical trials
25 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Belatacept in Heart Transplantation
- Enhancing Heart Allograft Function With the OCS Heart System Trial
- Randomized Trial of SGLT2i in Heart Transplant Recipients
- Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
- XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- Belatacept in De Novo Heart Transplantation
- Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
- Respiratory Strength Training in Heart Transplant Recipients
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
- Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
- Allograft Dysfunction in Heart Transplant
- US National OCS Heart Perfusion (OHP) Registry
- Heart Transplantation - Renewal
- Trifecta-Heart cfDNA-MMDx Study
- Cardiopulmonary Stress Testing (CPET) AlloSure Study
- Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- Genome Transplant Dynamics
- Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
- The Mycophenolate Pregnancy Registry
- Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)
- Daratumumab in HLA Desensitization Prior to Transplantation
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
- The Heart Health After Cardiac Treatment Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Heart Transplantation” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.